Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar

被引:5
作者
El-Hajj, Maguy S. [1 ,2 ]
Saad, Ahned [3 ]
Al-Suwaidi, Jassim [4 ]
Al-Marridi, Wafa Z. [5 ]
Elkhalifa, Dana H. [5 ]
Mohamed, Alaa A. [6 ]
Mahfoud, Ziyad R. [7 ]
机构
[1] Qatar Univ, Coll Pharm, Chair Clin Pharm, Doha 2713, Qatar
[2] Qatar Univ, Coll Pharm, Practice Sect, Doha 2713, Qatar
[3] Univ Arizona, Tucson, AZ USA
[4] Hamad Med Corp, Doha, Qatar
[5] Qatar Univ, Coll Pharm, Doha 2713, Qatar
[6] Hamad Med Corp, Heart Hosp, Doha, Qatar
[7] Weill Cornell Med, Hlth Policy & Res, Doha, Qatar
关键词
Acute Coronary Syndrome; secondary prevention; evidence-based medication; antiplatelets; beta eta-blocker; angiotensin converting enzyme inhibitor; angiotensin II receptor blocker; statin; Qatar; ACUTE MYOCARDIAL-INFARCTION; EVIDENCE-BASED THERAPY; QUALITY IMPROVEMENT; KIDNEY-DISEASE; BETA-BLOCKADE; TASK-FORCE; PREDICTORS; REHABILITATION; ATORVASTATIN; PRESCRIPTION;
D O I
10.2174/1570161114666160226150336
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Objectives: In Qatar, ACS (Acute Coronary Syndrome) has become the leading cause of morbidity and mortality. Guidelines recommend that ACS patients should receive indefinite treatment with antiplatelets, beta-blockers, angiotensin converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) and statins. The study objectives were to assess the use of evidence-based secondary prevention medication at discharge among ACS patients in Qatar and to determine the clinical and demographic characteristics associated with the use of these medications. Setting and Methods: A retrospective medical record review was conducted at the Heart Hospital in Qatar. A random sample of 1068 ACS patients was selected. Patient characteristics were summarized. Prevalence of medications at discharge were computed for each medication as well as for medication combinations. Multiple logistic regression was used to detect patient variables that were associated with the outcomes. A p <= 0.05 was considered significant Main Outcome Measures: -Percentage of ACS patients discharged on each of the following medications: antiplatelets (aspirin, clopidogrel), beta-blockers, ACEI or ARBs and statins and on the combination of these medications-Association between the use of these medications and patient characteristics Results: In total, 1064 records were reviewed. The majority were males (85.3%) and about 1 in 5 (18.7%) were Qatari. At discharge, patients were prescribed the following: aspirin (96.0%), clopidogrel (92.0%), beta-blockers (90.6%) and statins (97.7%). ACEI and ARBs were prescribed to 63.5 and 11.3%, respectively. The concurrent 4 medications (aspirin or clopidogrel, statins or other lowering cholesterol medication, beta-blockers and ACEI or ARB) were prescribed to 773 patients (77.8%; 95% confidence interval: 75.2-80.4%). Being overweight or obese, and having PCI (percutaneous coronary intervention) or hypertension were associated with higher prescription of the concurrent medications. Those with diabetes had a 52% increase in the odds of prescribing the 4 medications. Those with kidney disease had a 67% reduction in the odds of prescribing. Conclusion: Most ACS patients were prescribed antiplatelets, beta-blockers and statins, but the use of ACEIs or ARBs was suboptimal. Strategies are needed to enhance ACEI or ARB prescribing, especially for high risk patients who would have the greatest therapeutic benefit from these drugs.
引用
收藏
页码:394 / 403
页数:10
相关论文
共 50 条
[41]   Predictors of cardiovascular prognosis in patients receiving optimized secondary prevention measures after acute coronary syndrome [J].
Lafitte, Marianne ;
Pucheu, Yann ;
Latry, Karin ;
Dijos, Marina ;
Casassus, Eleonore ;
Couffinhal, Thierry .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2013, 20 (02) :283-290
[42]   Application effect of evidence-based nursing in perioperative period of acute coronary syndrome [J].
Liu, Juan ;
Zhong, Zhen ;
Ou, Shuyan ;
Peng, Kuang .
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04) :2653-2661
[43]   Use of Evidence-Based Interventions in Acute Coronary Syndrome - Subanalysis of the ACCEPT Registry [J].
Wang, Ricardo ;
Neuenschwander, Fernando Carvalho ;
Lima Filho, Augusto ;
Moreira, Celsa Maria ;
dos Santos, Elizabete Silva ;
Lima Reis, Helder Jose ;
Romano, Edson Renato ;
Piva e Mattos, Luiz Alberto ;
Berwanger, Otavio ;
de Andrade, Jadelson Pinheiro .
ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2014, 102 (04) :319-326
[44]   Optimal Medical Therapy for Non-ST-Segment-Elevation Acute Coronary Syndromes Exploring Why Physicians Do Not Prescribe Evidence-Based Treatment and Why Patients Discontinue Medications After Discharge [J].
Bagnall, Alan J. ;
Yan, Andrew T. ;
Yan, Raymond T. ;
Lee, Cindy H. ;
Tan, Mary ;
Baer, Carolyn ;
Polasek, Petr ;
Fitchett, David H. ;
Langer, Anatoly ;
Goodman, Shaun G. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (05) :530-537
[45]   Target Doses of Secondary Prevention Medications Are Not Being Achieved in Patients With Reduced Left Ventricular Ejection Fraction After Acute Coronary Syndrome (ANZACS-QI 34) [J].
Chan, Daniel ;
Doughty, Robert N. ;
Lund, Mayanna ;
Lee, Mildred ;
Kerr, Andrew J. .
HEART LUNG AND CIRCULATION, 2020, 29 (09) :1386-1396
[46]   Cost-benefit analysis of an evidence-based secondary prevention of coronary heart disease with statins [J].
Klever-Deichert, G ;
Hinzpeter, B ;
Wendland, G ;
Lauterbach, K .
MEDIZINISCHE KLINIK, 2000, 95 (06) :305-313
[47]   Secondary prevention therapies following percutaneous coronary intervention or acute coronary syndrome in patients with diabetes mellitus [J].
Planchat, Arnaud ;
Gencer, Baris ;
Degrauwe, Sophie ;
Musayeb, Yazan ;
Roffi, Marco ;
Iglesias, Juan F. .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
[48]   Impact of an Acute Coronary Syndrome Pathway in Achieving Target Heart Rate and Utilization of Evidence-Based Doses of Beta-Blockers [J].
Irani, Farzan ;
Herial, Nabeel ;
Colyer, William R., Jr. .
AMERICAN JOURNAL OF THERAPEUTICS, 2012, 19 (06) :397-402
[49]   Effect of a Multifaceted Intervention on Use of Evidence-Based Therapies in Patients With Acute Coronary Syndromes in Brazil The BRIDGE-ACS Randomized Trial [J].
Berwanger, Otavio ;
Guimaraes, Helio P. ;
Laranjeira, Ligia N. ;
Cavalcanti, Alexandre B. ;
Kodama, Alessandra A. ;
Zazula, Ana Denise ;
Santucci, Eliana V. ;
Victor, Elivane ;
Tenuta, Marcos ;
Carvalho, Vitor ;
Mira, Vera Lucia ;
Pieper, Karen S. ;
Weber, Bernardete ;
Mota, Luiz Henrique ;
Peterson, Eric D. ;
Lopes, Renato D. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (19) :2041-2049
[50]   Development and validation of medication assessment tools to evaluate prescribing adherence to evidence-based guidelines for secondary prevention of coronary heart disease in post-acute coronary syndromes patients in Kuwait [J].
Al-Taweel, Dalal ;
Awad, Abdelmoneim .
PLOS ONE, 2020, 15 (11)